Next Article in Journal
Formulation and Evaluation of Diltiazem Hydrochloride Gels for the Treatment of Anal Fissures
Previous Article in Journal
Development and Characterization of New Indomethacin Self-Nanoemulsifying Formulations
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 77
Issue 2
10.3797/scipharm.0806-08
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Preparation and In Vitro Evaluation of a Pegylated Nano-Liposomal Formulation Containing Docetaxel

by
Afrouz YOUSEFI
1,2,
Farnaz ESMAEILI
1,2,
Sima RAHIMIAN
2,
Fatemeh ATYABI
1 and
Rassoul DINARVAND
1,3,*
1
Novel Drug Delivery Systems Lab., Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, PO Box 14155-6451, Iran
2
Research and Development Dept., Sobhan Oncology Company, Rasht, Iran
3
Medical Nanotechnology Research Centre, Tehran University of Medical Sciences, Tehran, Iran
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(2), 453-464; https://doi.org/10.3797/scipharm.0806-08
Submission received: 9 June 2008 / Accepted: 18 March 2009 / Published: 19 March 2009
Versions Notes

Abstract

An improved pegylated liposomal formulation of docetaxel has been developed with the purpose of improving the docetaxel solubility without any need to use tween80 that is responsible for hypersensitivities following administration. Liposomes all had spherical shape with size of 130–160 nm. The most important finding of this study is that pegylated liposomes were prepared with significant increase in docetaxel encapsulation efficiency and stability of the formulation in comparison with last reports on docetaxel liposomes. In vitro release studies revealed that such a formulation could be stable in the blood circulation and meet the requirements for an effective drug delivery system.
Keywords: Docetaxel; Liposome; Stability; Pegylated; Nanoparticle Docetaxel; Liposome; Stability; Pegylated; Nanoparticle

Share and Cite

MDPI and ACS Style

YOUSEFI, A.; ESMAEILI, F.; RAHIMIAN, S.; ATYABI, F.; DINARVAND, R. Preparation and In Vitro Evaluation of a Pegylated Nano-Liposomal Formulation Containing Docetaxel. Sci. Pharm. 2009, 77, 453-464. https://doi.org/10.3797/scipharm.0806-08

AMA Style

YOUSEFI A, ESMAEILI F, RAHIMIAN S, ATYABI F, DINARVAND R. Preparation and In Vitro Evaluation of a Pegylated Nano-Liposomal Formulation Containing Docetaxel. Scientia Pharmaceutica. 2009; 77(2):453-464. https://doi.org/10.3797/scipharm.0806-08

Chicago/Turabian Style

YOUSEFI, Afrouz, Farnaz ESMAEILI, Sima RAHIMIAN, Fatemeh ATYABI, and Rassoul DINARVAND. 2009. "Preparation and In Vitro Evaluation of a Pegylated Nano-Liposomal Formulation Containing Docetaxel" Scientia Pharmaceutica 77, no. 2: 453-464. https://doi.org/10.3797/scipharm.0806-08

APA Style

YOUSEFI, A., ESMAEILI, F., RAHIMIAN, S., ATYABI, F., & DINARVAND, R. (2009). Preparation and In Vitro Evaluation of a Pegylated Nano-Liposomal Formulation Containing Docetaxel. Scientia Pharmaceutica, 77(2), 453-464. https://doi.org/10.3797/scipharm.0806-08

Article Metrics

Back to TopTop